05.03.24 -- NK Cell Therapies: How Artiva Biotherapeutics Leverages Its "Manufacturing First" Approach

Understanding the Fc region of your antibody is crucial for assessing the impact on immunology, safety, and efficacy. Explore how to determine the most efficient way to test functionality.

Review a well-established platform process for lentiviral vector (LV) production based on transient transfection of serum-free cells grown in suspension.

Learn how a partner with expertise and a comprehensive range of services can help companies create efficient and effective manufacturing processes, ultimately leading to successful commercialization.

What quality attributes may be similar across products, and which will be different? Explore the important differentiation of what is a critical quality attribute (CQA) versus a quality attribute.

Explore evidence that mass photometry is a favorable method due to its accuracy, versatility, and low time, sample, and expertise requirements.

Delve into the current challenges and opportunities of therapeutic targets, manufacturing processes, and regulatory frameworks for CGTs and realize the full potential of these revolutionary therapies.

Quality by design (QbD) achieves quality through an understanding of all components and processes, with a detailed understanding of risks and how they can be mitigated.

As Raman spectroscopy, with partial least squares (PLS) models, becomes more popular in bioprocesses applications it's important to recognize the challenges this approach presents.

Improve your mAb production by adopting a technology platform approach using a fluid handling system that can transition from development to your final production volume.

Emerging and novel uses for osmolality testing in advanced therapy production is helping developers address the challenges of making cell and gene therapies accessible to larger patient populations.

Examine why template sequence characteristics are relevant for cGMP manufacturing of high-quality mRNA and consider insights on how to develop a scalable, robust, and economically viable process.

Learn why endotoxin testing has become integral to the development and quality control of injectable pharmaceuticals and medical devices and the development and advantages of kinetic LAL assays.

The demand for high-concentration/subcutaneous drugs is on the rise. Explore opportunities for enhancing your biotech drug production platform.

Lean construction, as a buzzword, gets a lot of play in the cleanroom industry for good reason. It is an idea that got its start with Toyota in the 1950s to maximize efficiency and eliminate waste in production.

This chapter of The Aqueous Cleaning Handbook explains what an aqueous cleaner is, what it contains, and how it can improve your cleaning process.